Pharmaceutical Information |
Drug Name |
Daunorubicin |
Drug ID |
BADD_D00590 |
Description |
A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of leukemia and other neoplasms. |
Indications and Usage |
For remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults. |
Marketing Status |
Prescription; Discontinued |
ATC Code |
L01DB02 |
DrugBank ID |
DB00694
|
KEGG ID |
D07776
|
MeSH ID |
D003630
|
PubChem ID |
30323
|
TTD Drug ID |
D01XWG
|
NDC Product Code |
Not Available |
Synonyms |
Daunorubicin | Daunomycin | Rubomycin | Dauno-Rubidomycine | Dauno Rubidomycine | Rubidomycin | Daunoblastin | Daunoblastine | NSC-82151 | NSC 82151 | NSC82151 | Cerubidine | Daunorubicin Hydrochloride | Hydrochloride, Daunorubicin |
|
Chemical Information |
Molecular Formula |
C27H29NO10 |
CAS Registry Number |
20830-81-3 |
SMILES |
CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
|